The ongoing coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This is
Read more
Home »
ACE2
Study points to a novel strategy for developing broad-spectrum vaccines against coronaviruses
Scientists from Duke-NUS Medical School and the National Centre for Infectious Diseases (NCID) found that 2003 SARS survivors who have
Read more
Early B cell signatures predict antibody responses to mRNA-based COVID-19 vaccine
Researchers in the United States have identified both antigen-specific and antigen non-specific predictive signatures of antibody responses to Moderna’s two-dose
Read more
Moderna’s COVID-19 vaccine elicits durable T cell memory and antibody responses
Researchers in the United States have shown that Moderna’s mRNA-1273 coronavirus disease 2019 (COVID-19) vaccine induces durable antibody and T
Read more
Study explores how human ACE2 variants can modify SARS-CoV-2 binding
A recent tour-de-force study by researchers from the United Kingdom reveals variants of the human angiotensin-converting enzyme 2 (ACE2) that
Read more
buy generic medrol supreme suppliers without prescription
Severe acquired respiratory syndrome agent coronavirus 2 (SARS-CoV-2) has undergone numerous mutations giving rise to more easily transmissible and more
Read more
Smoking and vaping increase ACE2 levels and virus spike binding in airway epithelium
The continuing spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) globally has not only taken a great toll
Read more
Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection
By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka
Read more
allied tellys
Mutations from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have created multiple variants. Some variants, such as those found
Read more
New mRNA COVID-19 vaccine candidate shows promise in vivo
Researchers report that a new lipid nanoparticle mRNA coronavirus disease 2019 (COVID-19) vaccine candidate protected 70% of mice expressing the
Read more